- Home
- IVP vs CNSP Comparison
IVP vs CNSP Comparison
Compare IVP & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- CNSP
- Stock Information
- Founded
- IVP 2020
- CNSP 2017
- Country
- IVP United States
- CNSP United States
- Employees
- IVP N/A
- CNSP N/A
- Industry
- IVP Diversified Commercial Services
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- IVP Miscellaneous
- CNSP Health Care
- Exchange
- IVP Nasdaq
- CNSP Nasdaq
- Market Cap
- IVP 3.4M
- CNSP 4.0M
- IPO Year
- IVP 2023
- CNSP 2019
- Fundamental
- Price
- IVP $0.99
- CNSP $9.22
- Analyst Decision
- IVP
- CNSP Strong Buy
- Analyst Count
- IVP 0
- CNSP 1
- Target Price
- IVP N/A
- CNSP $20.00
- AVG Volume (30 Days)
- IVP 166.9K
- CNSP 51.4K
- Earning Date
- IVP 11-12-2025
- CNSP 11-14-2025
- Dividend Yield
- IVP N/A
- CNSP N/A
- EPS Growth
- IVP N/A
- CNSP N/A
- EPS
- IVP N/A
- CNSP N/A
- Revenue
- IVP $15,292,904.00
- CNSP N/A
- Revenue This Year
- IVP N/A
- CNSP N/A
- Revenue Next Year
- IVP N/A
- CNSP N/A
- P/E Ratio
- IVP N/A
- CNSP N/A
- Revenue Growth
- IVP N/A
- CNSP N/A
- 52 Week Low
- IVP $0.63
- CNSP $4.93
- 52 Week High
- IVP $24.61
- CNSP $221.94
- Technical
- Relative Strength Index (RSI)
- IVP 51.76
- CNSP 57.34
- Support Level
- IVP $0.93
- CNSP $8.50
- Resistance Level
- IVP $1.00
- CNSP $10.59
- Average True Range (ATR)
- IVP 0.07
- CNSP 0.56
- MACD
- IVP -0.01
- CNSP -0.08
- Stochastic Oscillator
- IVP 28.60
- CNSP 37.93
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.